RoyaLand unveils details for Palazzo Chronicles mobile game
RoyaLand Co Ltd. announces details of its upcoming mobile game, Palazzo Chronicles, blending match-3 puzzles with a rich narrative, set for Q4 2026 launch.
Zhihu Inc. Approves RMB1.5 Billion Capital Commitment
Zhihu Inc. has passed a resolution for a RMB1.5 billion capital commitment, enhancing its investment strategy and growth potential.
Wise Group plc repurchases over 1.3 million shares
Wise Group plc has repurchased over 1.3 million shares, reflecting its commitment to shareholder value and impacting the business services industry.
ZTO Express announces share repurchase program in filing
ZTO Express reveals a share repurchase program, signaling a focus on shareholder value amidst competition in the trucking and courier services sector.
Zhihu Inc. Announces Share Repurchase Program Update
Zhihu Inc. reports share repurchases, signaling confidence in future performance and impacting the business services sector.
KE Holdings Reports Share Repurchases in Latest Filing
KE Holdings Inc. details recent share repurchases in a new filing, emphasizing its commitment to shareholder value in the real estate sector.
Brightstar Lottery PLC Announces $3.5 Million Share Buyback
Brightstar Lottery PLC has repurchased 330,400 shares for $3.5 million as part of its $500 million buyback program, enhancing shareholder value.
Aeromexico Gains Flexibility After U.S. DOT Revokes Service Limits
Grupo Aeromexico can now expand its flight offerings after the U.S. DOT revokes previous restrictions on Mexico-U.S. air service.
GSK's Hibsago Receives FDA Approval for Chronic Hepatitis B
GSK plc's Hibsago gains FDA approval for chronic hepatitis B, offering new hope for patients with significant cure rates over existing therapies.
TH International Ltd issues new convertible notes, adds director
TH International Ltd issues $14.37 million in convertible notes and appoints Stanford Ming Lin as a new director, enhancing its leadership and financial strength.
Dollar General sued by FTC over marketing practices
Dollar General faces a lawsuit from the FTC alleging violations in marketing practices, which could significantly impact the company's financial health.
North Haven Private Income Fund reports unregistered equity sales
North Haven Private Income Fund LLC announces unregistered sales of equity securities, signaling strategic fundraising efforts.
STRATS Trust for Dominion Resources announces certificate distribution
STRATS Trust for Dominion Resources, Inc. Securities announces a distribution to certificate holders, reflecting ongoing activity in asset-backed securities.
STRATS SM Trust Announces Distribution to Certificate Holders
STRATS SM Trust for Wal-Mart Stores, Inc. Securities has announced a distribution to its certificate holders, reflecting ongoing activity in the asset-backed securities market.
North Haven Private Income Fund A LLC Reports Equity Sales
North Haven Private Income Fund A LLC has disclosed unregistered sales of equity securities, signaling a strategic move to enhance capital.
Sculptor Diversified Real Estate Income Trust launches new shares
Sculptor Diversified Real Estate Income Trust announces new share classes to enhance capital structure, reflecting trends in the Real Estate Investment Trusts sector.
Equillium announces milestone in EQ504 clinical trial
Equillium, Inc. announces the dosing of its first patient in a clinical trial for EQ504, triggering a $20 million funding milestone.
New Mountain Finance Corp Extends Stock Repurchase Program
New Mountain Finance Corp has extended its stock repurchase program, allowing for up to $150 million in buybacks through December 31, 2027.
Apollo Infrastructure issues unregistered shares to investors
Apollo Infrastructure Co LLC has issued unregistered shares to third-party investors, enhancing its capital strategy in the Electric, Gas & Sanitary Services sector.
Lycia Therapeutics amends articles of incorporation, bylaws
Lycia Therapeutics has amended its articles of incorporation and bylaws following its IPO, signaling a strategic shift in the biological products sector.